BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17537042)

  • 1. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau.
    Weisshaar E; Diepgen TL
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):489-92. PubMed ID: 17537042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
    Silpa-archa N; Wongpraparut C
    J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
    Thielen AM; Barde C; Marazza G; Saurat JH
    Dermatology; 2008; 217(2):137-9. PubMed ID: 18503258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept responsive acrodermatitis continua of Hallopeau: is a pattern developing?
    Bonish B; Rashid RM; Swan J
    J Drugs Dermatol; 2006 Oct; 5(9):903-4. PubMed ID: 17039659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
    Kazinski K; Joyce KM; Hodson D
    J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two years of experience with etanercept in recalcitrant psoriasis.
    Ahmad K; Rogers S
    Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau.
    Adişen E; Oztaş M; Gürer MA
    Int J Dermatol; 2007 Nov; 46(11):1205-7. PubMed ID: 17988345
    [No Abstract]   [Full Text] [Related]  

  • 8. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
    Nikkels AF; Piérard GE
    J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breaking the relentless course of Hallopeau's acrodermatitis by dapsone.
    Nikkels AF; Nikkels-Tassoudji N; Piérard GE
    Eur J Dermatol; 1999 Mar; 9(2):126-8. PubMed ID: 10066962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrodermatitis continua resistant to etanercept: therapeutic challenge and unfortunate outcome.
    Gokdemir G; Kutlu S; Köşlü A
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):345-7. PubMed ID: 18554224
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment for acrodermatitis continua of Hallopeau using topical calcipotriol.
    Emtestam L; Wedén U
    Br J Dermatol; 1996 Oct; 135(4):644-6. PubMed ID: 8915165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
    Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P; Del Giglio M; Cotena C; Girolomoni G
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
    Campione E; Mazzotta A; Paternò EJ; Diluvio L; Prinz JC; Chimenti S
    Acta Derm Venereol; 2009; 89(3):288-91. PubMed ID: 19479128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PUVA-bath photochemotherapy in Hallopeau's acrodermatitis continua suppurativa].
    Behrens S; von Kobyletzki G; Hoffmann K; Altmeyer P; Kerscher M
    Hautarzt; 1997 Nov; 48(11):824-7. PubMed ID: 9518245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case reports: treatment of atypical hidradenitis suppurativa with the tumor necrosis factor receptor-Fc fusion protein etanercept.
    Henderson RL
    J Drugs Dermatol; 2006; 5(10):1010-1. PubMed ID: 17373153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parapharyngeal abscess in a patient receiving etanercept.
    Borrás-Blasco J; Nuñez-Cornejo C; Gracia-Perez A; Rosique-Robles JD; Casterá MD; Viosca E; Abad FJ
    Ann Pharmacother; 2007 Feb; 41(2):341-4. PubMed ID: 17227824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment.
    Wilsmann-Theis D; Hagemann T; Dederer H; Wenzel J; Bieber T; Novak N
    Br J Dermatol; 2004 Jun; 150(6):1194-7. PubMed ID: 15214910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.